Detail of the clinical trial
| Title of the trial | A Phase 3 Randomized, Open-Label Study of Ponatinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase |
|---|---|
| EudraCT number | 2012-001355-38 |
| Protocol number | AP24534-12-301 |
| Sponsor | Ariad Pharmaceticals, Inc., 26 landsdowne Street, MA 02139 Cambridge, USA |
| Indications | Hemato-oncology |
| Diagnosis | Chronic Myeloid Leukemia in Chronic Phase |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2012 |
| Date of approval by Institute (SÚKL) | 17.12.2012 |
| Date of approval by EC | 12.12.2012 |
| Date of initiation CT in ČR | |
| Date of ending CT in ČR | 30.10.2013 (17.10.2013) |
| Notice | |
| Sites |
Ústav hematologie a krevní transfuze Fakultní nemocnice Hradec Králové, IV. interní hematologická klinika Fakultní nemocnice Brno, Interní hematologická a onkologická klinika |
cz